Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom.
Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom.
复制标题
使用基于风险的分层对从初级保健到英国专业护理的慢性肾脏疾病患者转诊的影响。
DOI:
10.1016/j.ekir.2021.05.031
复制
发表时间:
2021-08
影响因子:
6
通讯作者:
Calvert M
中科院分区:
文献类型:
--
作者:
Bhachu HK;Cockwell P;Subramanian A;Adderley NJ;Gokhale K;Fenton A;Kyte D;Nirantharakumar K;Calvert M
The externally validated Kidney Failure Risk Equation (KFRE) for predicting risk of end-stage renal disease (ESRD) has been developed, but its potential impact in a population on referrals for patients with chronic kidney disease (CKD) from primary to specialty nephrology care is not known. A cross-sectional population-based study of individuals in United Kingdom primary care registered in The Health Improvement Network database was conducted. National Institute of Health and Care Excellence (NICE) 2014 CKD guidelines versus the 4-variable KFRE set at a >3% risk of ESRD at 5 years were applied to patients identified with CKD stage 3-5 between January 1, 2016, and March 31, 2017. In all, 39,476 (36.6%) of 107,962 adults with CKD stage 3-5 had a urine albumin:creatinine ratio (ACR) available and entered into the primary analysis. Of that, 7566 (19.2%) patients fulfilled NICE criteria for referral, 2386 (31.5%) of whom had a ≤3% 5-year risk of ESRD. Also 8663 (21.9%) patients had a >3% 5-year risk of ESRD, 3483 (40.2%) of whom did not fulfill NICE criteria; this represents 8.8% of the primary population. By using the KFRE threshold rather than NICE criteria for referral, 5869 patients (14.9% of the primary analysis population) would have been reallocated between primary and specialist care. Imputational analysis was used for missing ACR measurements and showed similar results. A risk-based referral approach would lead to a substantial reallocation of patients between primary care and specialist nephrology care with only a small increase in numbers eligible, ensuring those at higher risk of progression are identified.
登录
查看更多内容
DOI:
10.1136/bmj.f324
发表时间:
2013-01-29
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Nitsch D;Grams M;Sang Y;Black C;Cirillo M;Djurdjev O;Iseki K;Jassal SK;Kimm H;Kronenberg F;Oien CM;Levey AS;Levin A;Woodward M;Hemmelgarn BR;Chronic Kidney Disease Prognosis Consortium
通讯作者:
Chronic Kidney Disease Prognosis Consortium
影响因子:
15.8
作者:
Major, Rupert W.;Shepherd, David;Brunskill, Nigel J.
通讯作者:
Brunskill, Nigel J.
影响因子:
158.5
作者:
Perkovic, V.;Jardine, M. J.;Bentley-Lewis, Rhonda
通讯作者:
Bentley-Lewis, Rhonda
DOI:
10.2215/cjn.08110715
发表时间:
2016-04-01
影响因子:
9.8
作者:
Lennartz, Claudia S.;Pickering, John William;Heine, Gunnar H.
通讯作者:
Heine, Gunnar H.
影响因子:
120.7
作者:
Hallan, Stein I.;Matsushita, Kunihiro;Sang, Yingying;Mahmoodi, Bakhtawar K.;Black, Corri;Ishani, Areef;Kleefstra, Nanne;Naimark, David;Roderick, Paul;Tonelli, Marcello;Wetzels, Jack F. M.;Astor, Brad C.;Gansevoort, Ron T.;Levin, Adeera;Wen, Chi-Pang;Coresh, Josef
通讯作者:
Coresh, Josef